CureVac raised €100M in a Series D+ round in Nov 2015. The company is based in T√ºbingen, Germany. Investors in the round: Baillie Gifford. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
